» Articles » PMID: 18284275

Treatment Strategies to Prevent Relapse and Encourage Remission

Overview
Specialty Psychiatry
Date 2008 Feb 26
PMID 18284275
Citations 54
Authors
Affiliations
Soon will be listed here.
Abstract

Remission is a realistic goal for patients with schizophrenia, and, if sustained remission without relapse can be achieved, then patients may attain functional recovery. With each relapse, recovery can be slowed and the course of illness worsened. The risk of self-harm and harm to others increases with each psychotic episode. The chance of relapse is decreased if pharmacotherapy continues uninterrupted, and one strategy to ensure continuous treatment is using long-acting injectable antipsychotic medications. Achieving remission of schizophrenia is clinically meaningful because, besides symptom control, remission allows for improved vocational and social functioning. Functional recovery without relapse allows patients to return to work, sustain interpersonal relationships, and lead more productive lives. Therefore, achieving the goals of remission and recovery is in the best interest not only of patients with schizophrenia but also of society.

Citing Articles

Prediction of functional remission in patients with schizophrenia after antipsychotic discontinuation (FURSAD): protocol for a real-world case-control study.

Lu C, Dong Y, Zhai Z, Gao T, Luo M, Feng T BMJ Open. 2024; 14(12):e087645.

PMID: 39732483 PMC: 11683939. DOI: 10.1136/bmjopen-2024-087645.


Guideline for pharmacological treatment of schizophrenia 2022.

Neuropsychopharmacol Rep. 2024; 45(1):e12497.

PMID: 39587785 PMC: 11666347. DOI: 10.1002/npr2.12497.


TV-46000, A Long-Acting Subcutaneous Antipsychotic Agent, Demonstrated Improved Patient-Centered Outcomes in Patients with Schizophrenia.

Citrome L, Suett M, Franzenburg K, Eshet R, Elgart A, Davis Rd G Neuropsychiatr Dis Treat. 2024; 20:1901-1917.

PMID: 39399879 PMC: 11471067. DOI: 10.2147/NDT.S459104.


Risk factors and strategies for relapse prevention among individuals living with serious mental illness in South Africa: Qualitative inquiry from patients' and caregivers' perspectives.

Mlay J, Naidu T, Ramlall S, Mhlungu S, Zondi M, Lessells R PLoS One. 2024; 19(8):e0309238.

PMID: 39172928 PMC: 11340960. DOI: 10.1371/journal.pone.0309238.


Real-world predictors of relapse in patients with schizophrenia and schizoaffective disorder in a large health system.

Rivelli A, Fitzpatrick V, Nelson M, Laubmeier K, Zeni C, Mylavarapu S Schizophrenia (Heidelb). 2024; 10(1):28.

PMID: 38424086 PMC: 10904733. DOI: 10.1038/s41537-024-00448-2.